Yuyantang Emerges as Key Player in Traditional Chinese Medicine Sector Amid Hong Kong IPO Push

Yuyantang, the fifth-largest private provider of traditional Chinese medicine services in China, has filed for an IPO in Hong Kong after reporting significant revenue and profit growth. Founded in 2015 by Guo Yang, the company specializes in treating chronic diseases such as chest heart disease, stroke, hypertension, insomnia, and diabetes. Yuyantang has expanded its presence beyond its Northeastern China base to affluent regions like Jiangsu province, operating 59 physical institutions as of May this year. Yuyantang differentiates itself by directly managing all its centers, ensuring consistency in clinical protocols, service quality, and brand standards. The company’s revenue driver is its…